SALT LAKE CITY, Utah, Nov. 2, 2015 – Myriad Genetics, Inc. (NASDAQ: MYGN) today announced that it has launched an online and social media campaign to encourage families to talk about their health history this holiday season. The Surgeon General has designated November as Family Health History Month and Thanksgiving as Family Health History Day and Myriad’s campaign coincides with these initiatives.
The campaign urges individuals to discuss hereditary cancer with their families during holiday gatherings. Individuals are also encouraged to take a hereditary cancer quiz developed by Myriad to find out if they may be at risk of the disease. They are also encouraged to share the results with other family members and their healthcare providers. Mutations or variations in genes passed from parent to child can drastically increase the risk of cancer. In fact, certain inherited syndromes can lead to nearly a 100% chance of getting certain types of cancer. Fortunately, knowing about this risk can save lives and help physicians determine the best course of treatment for individual patients. Knowledge truly is power. In addition to the hereditary cancer quiz, an infographic with facts about hereditary cancer will appear on Myriad’s website and be promoted on our social media channels.
For more information on the campaign visit www.myriad.com and follow us on Facebook (https://www.facebook.com/MyriadGenetics), Twitter (@MyriadGenetics) and LinkedIn (https://www.linkedin.com/company/myriad-genetics).
About Myriad Genetics
Myriad Genetics Inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. Myriad is focused on three strategic imperatives: transitioning and expanding its hereditary cancer testing markets, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets. For more information on how Myriad is making a difference, please visit the Company’s website: www.myriad.com.
Help employers find you! Check out all the jobs and post your resume.
